Healthy volunteers help check if two pill strengths are equal
NCT ID NCT05390944
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This completed phase 1 trial tested whether two different strengths (10 mg and 20 mg) of the experimental drug IMP4297 are processed the same way in the body. Twenty-eight healthy Chinese men each took a single dose of both strengths, with a week between doses. The study measured drug levels in the blood over 72 hours to compare how the body absorbs and handles each strength.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- IMP4297
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xuzhou Central Hospital
Xuzhou, Jiangsu, 221000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a Tumor's DNA guide better cancer care for kids?
- Can a new PET tracer reveal a key cancer target?
- Can a smart drug home in on Hard-to-Treat cancers?
- Can a new tracer light up cancer growth?
- Can a Dual-Pronged antibody outsmart advanced cancers?